Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|FGFR2 H167_N173del FGFR2 L617F||intrahepatic cholangiocarcinoma||predicted - resistant||Debio 1347||Case Reports/Case Series||Actionable||In a clinical study, a patient with intrahepatic cholangiocarcinoma harboring FGFR2 H167_N173del developed resistance to Debio 1347 treatment after initial response, FGFR2 L617F was identified as an acquired mutation at disease progression (J Clin Oncol 38, 2020 (suppl 4; abstr 567)).||detail...|
|PubMed Id||Reference Title||Details|
|Therapeutic targeting of extracellular FGFR2 activating deletions in intrahepatic cholangiocarcinoma.||Full reference...|